134 related articles for article (PubMed ID: 1812289)
21. Ultrastructural and electron-immunocytochemical characterization of cells in epiretinal membranes.
Vinores SA; Campochiaro PA; Conway BP
Invest Ophthalmol Vis Sci; 1990 Jan; 31(1):14-28. PubMed ID: 1688833
[TBL] [Abstract][Full Text] [Related]
22. Chemokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy.
Abu El-Asrar AM; Struyf S; Kangave D; Geboes K; Van Damme J
Eur Cytokine Netw; 2006 Sep; 17(3):155-65. PubMed ID: 17194635
[TBL] [Abstract][Full Text] [Related]
23. The pathogenesis of vitreoretinal proliferation and traction: a working hypothesis.
Weller M; Heimann K; Wiedemann P
Med Hypotheses; 1990 Feb; 31(2):157-9. PubMed ID: 2325589
[TBL] [Abstract][Full Text] [Related]
24. Acidic FGF and other growth factors in preretinal membranes from patients with diabetic retinopathy and proliferative vitreoretinopathy.
Fredj-Reygrobellet D; Baudouin C; Nègre F; Caruelle JP; Gastaud P; Lapalus P
Ophthalmic Res; 1991; 23(3):154-61. PubMed ID: 1719460
[TBL] [Abstract][Full Text] [Related]
25. [Idiopathic proliferative vitreoretinopathy. Activation of microglial cells as the deciding factor].
Weller M; Esser P; Heimann K; Wiedemann P
Ophthalmologe; 1992 Oct; 89(5):387-90. PubMed ID: 1304218
[TBL] [Abstract][Full Text] [Related]
26. Immunocytochemical study of cells in the vitreous of proliferative vitreoretretinopathy.
Liu B; Hui Y; Ma J; Du H
Yan Ke Xue Bao; 1999 Mar; 15(1):13-6. PubMed ID: 12579654
[TBL] [Abstract][Full Text] [Related]
27. Vitreous vascular endothelial growth factor concentrations in proliferative diabetic retinopathy versus proliferative vitreoretinopathy.
Citirik M; Kabatas EU; Batman C; Akin KO; Kabatas N
Ophthalmic Res; 2012; 47(1):7-12. PubMed ID: 21691136
[TBL] [Abstract][Full Text] [Related]
28. Soluble TNF receptors in vitreoretinal proliferative disease.
Limb GA; Hollifield RD; Webster L; Charteris DG; Chignell AH
Invest Ophthalmol Vis Sci; 2001 Jun; 42(7):1586-91. PubMed ID: 11381065
[TBL] [Abstract][Full Text] [Related]
29. Immunocytology of cellular components in vitreous and subretinal fluid from patients with proliferative vitreoretinopathy.
Baudouin C; Hofman P; Brignole F; Bayle J; Loubière R; Gastaud P
Ophthalmologica; 1991; 203(1):38-46. PubMed ID: 1766640
[TBL] [Abstract][Full Text] [Related]
30. Epithelial-mesenchymal transition in proliferative vitreoretinopathy: intermediate filament protein expression in retinal pigment epithelial cells.
Casaroli-Marano RP; Pagan R; Vilaró S
Invest Ophthalmol Vis Sci; 1999 Aug; 40(9):2062-72. PubMed ID: 10440262
[TBL] [Abstract][Full Text] [Related]
31. Plasminogen in proliferative vitreoretinal disorders.
Esser P; Heimann K; Bartz-Schmidt KU; Walter P; Krott R; Weller M
Br J Ophthalmol; 1997 Jul; 81(7):590-4. PubMed ID: 9290376
[TBL] [Abstract][Full Text] [Related]
32. The extracellular matrix of reparative tissue in the vitreous: fibronectin production in proliferative diabetic retinopathy membranes.
Hiscott P; Waller HA; Grierson I; Butler MG; Scott DL
Eye (Lond); 1993; 7 ( Pt 2)():288-92. PubMed ID: 7607348
[TBL] [Abstract][Full Text] [Related]
33. Transferrin receptor expression by retinal pigment epithelial cells in proliferative vitreoretinopathy.
Baudouin C; Brignole F; Fredj-Reygrobellet D; Nègre F; Bayle J; Gastaud P
Invest Ophthalmol Vis Sci; 1992 Sep; 33(10):2822-9. PubMed ID: 1382045
[TBL] [Abstract][Full Text] [Related]
34. Oxytalan fibres in proliferative vitreoretinopathy.
Alexander RA; Hiscott P; McGalliard J; Grierson I
Ger J Ophthalmol; 1992; 1(6):382-7. PubMed ID: 1490137
[TBL] [Abstract][Full Text] [Related]
35. The process of subretinal strand formation.
Okada M; Ogino N; Matsumura M; Honda Y; Nagai Y
Jpn J Ophthalmol; 1992; 36(2):222-34. PubMed ID: 1513070
[TBL] [Abstract][Full Text] [Related]
36. Immunochemical studies of epiretinal membranes using APAAP complexes: evidence for macrophage involvement in traumatic proliferative vitreoretinopathy.
Weller M; Heimann K; Wiedemann P
Int Ophthalmol; 1988 Jan; 11(3):181-6. PubMed ID: 2458325
[TBL] [Abstract][Full Text] [Related]
37. Vitreous levels of soluble vascular endothelial growth factor receptor (VEGFR)-1 in eyes with vitreoretinal diseases.
Asato R; Kita T; Kawahara S; Arita R; Mochizuki Y; Aiello LP; Ishibashi T
Br J Ophthalmol; 2011 Dec; 95(12):1745-8. PubMed ID: 21719570
[TBL] [Abstract][Full Text] [Related]
38. Upregulation of Mir-21 Levels in the Vitreous Humor Is Associated with Development of Proliferative Vitreoretinal Disease.
Usui-Ouchi A; Ouchi Y; Kiyokawa M; Sakuma T; Ito R; Ebihara N
PLoS One; 2016; 11(6):e0158043. PubMed ID: 27351379
[TBL] [Abstract][Full Text] [Related]
39. Active scatter factor (HGF/SF) in proliferative vitreoretinal disease.
Briggs MC; Grierson I; Hiscott P; Hunt JA
Invest Ophthalmol Vis Sci; 2000 Sep; 41(10):3085-94. PubMed ID: 10967068
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemical study of angiogenesis and proliferative activity in epiretinal membranes.
Tsanou E; Ioachim E; Stefaniotou M; Gorezis S; Charalabopoulos K; Bagli H; Peschos D; Psilas K; Agnantis NJ
Int J Clin Pract; 2005 Oct; 59(10):1157-61. PubMed ID: 16178982
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
